当前位置: X-MOL 学术BMC Surg. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Identifying risk factors for metastasis to the level VII lymph node in papillary thyroid carcinoma patients.
BMC Surgery ( IF 1.9 ) Pub Date : 2020-01-14 , DOI: 10.1186/s12893-020-0675-5
Jian Chen 1 , Deguang Zhang 1 , Liang Fang 1 , Gaofei He 1 , Li Gao 1
Affiliation  

BACKGROUND The level VI lymph nodes are anatomically connected to the level VII lymph nodes and papillary thyroid carcinoma (PTC) can metastasis to both regions. The aim of this study was to identify clinicopathologic factors associated with level VII lymph node metastasis. METHODS Between March 2015 and September 2016, a total of 275 consecutive patients were operated on for PTC with prophylactic level VII dissection at the Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, ZheJiang, China. Patients with PTC were performed via video-assisted approach. Multivariate logistic regression analysis was performed to evaluate the associations between clinicopathologic factors. RESULTS Of the 275 subjects enrolled in this study, 79 patients (28.73%) showed lymph node metastasis to the level VII. The multivariate logistic regression analysis showed ultrasonography-positive lymph nodes (p < 0.001), the location of primary carcinoma (p = 0.002) and hashimoto thyroiditis (HT) (p = 0.04) were associated with level VII lymph node metastasis. CONCLUSIONS Based on the results of our study, we considered central-compartment lymph node dissection (CLND) as an integral strategy. On the basis of surgery safety, transcervical level VII lymph node dissection could be considered for PTC patients with high risk factors such as ultrasonography-positive lymph nodes, tumor located in middle and lower thirds of the thyroid lobe and the patients without HT. In future, prognostic significance of level VII lymph node dissection should be evaluated through long-term surveillance.

中文翻译:

确定甲状腺乳头状癌患者转移至VII级淋巴结的危险因素。

背景技术VI级淋巴结在解剖上与VII级淋巴结相连,甲状腺乳头状癌(PTC)可以转移到这两个区域。这项研究的目的是确定与VII级淋巴结转移相关的临床病理因素。方法2015年3月至2016年9月,在浙江大学医学院附属邵逸夫医院对275例行PTC预防性VII夹层手术的患者进行了手术。PTC患者通过视频辅助方法进行。进行多因素logistic回归分析以评估临床病理因素之间的关联。结果在该研究的275名受试者中,有79名患者(28.73%)显示出淋巴结转移至VII级。多元logistic回归分析显示,超声检查阳性的淋巴结转移(p <0.001),原发癌的位置(p = 0.002)和桥本甲状腺炎(HT)(p = 0.04)与VII级淋巴结转移有关。结论基于我们的研究结果,我们认为中央室淋巴结清扫术(CLND)是一项整体策略。基于手术安全性,对于超声检查阳性的淋巴结,位于甲状腺叶中下三分之内的肿瘤以及无HT的高危因素的PTC患者,可考虑行宫颈VII级淋巴结清扫术。将来,应通过长期监测评估VII级淋巴结清扫的预后意义。原发癌(p = 0.002)和桥本甲状腺炎(HT)(p = 0.04)的位置与VII级淋巴结转移有关。结论基于我们的研究结果,我们认为中央室淋巴结清扫术(CLND)是一项整体策略。基于手术安全性,对于超声检查阳性的淋巴结,位于甲状腺叶中下三分之内的肿瘤以及无HT的高危因素的PTC患者,可考虑行宫颈VII级淋巴结清扫术。将来,应通过长期监测评估VII级淋巴结清扫的预后意义。原发癌(p = 0.002)和桥本甲状腺炎(HT)(p = 0.04)的位置与VII级淋巴结转移有关。结论基于我们的研究结果,我们认为中央室淋巴结清扫术(CLND)是一项整体策略。基于手术安全性,对于超声检查阳性的淋巴结,位于甲状腺叶中下三分之内的肿瘤以及无HT的高危因素的PTC患者,可考虑行宫颈VII级淋巴结清扫术。将来,应通过长期监测评估VII级淋巴结清扫的预后意义。我们认为中央室淋巴结清扫(CLND)是一项整体策略。基于手术安全性,对于超声检查阳性的淋巴结,位于甲状腺叶中下三分之内的肿瘤以及无HT的高危因素的PTC患者,可考虑行宫颈VII级淋巴结清扫术。将来,应通过长期监测评估VII级淋巴结清扫的预后意义。我们认为中央室淋巴结清扫(CLND)是一项整体策略。基于手术安全性,对于超声检查阳性的淋巴结,位于甲状腺叶中下三分之内的肿瘤以及无HT的高危因素的PTC患者,可考虑行宫颈VII级淋巴结清扫术。将来,应通过长期监测评估VII级淋巴结清扫的预后意义。
更新日期:2020-01-15
down
wechat
bug